Rabbit Recombinant Monoclonal PGP9.5 antibody. Suitable for Flow Cyt, ICC, IHC-P, WB and reacts with Mouse, Human samples. Immunogen corresponding to Synthetic Peptide within Human UCHL1 aa 50-100.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline
Flow Cyt | ICC | IHC-P | WB | |
---|---|---|---|---|
Human | Tested | Tested | Tested | Tested |
Mouse | Tested | Expected | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info - | Notes - |
Deubiquitinase that plays a role in the regulation of several processes such as maintenance of synaptic function, cardiac function, inflammatory response or osteoclastogenesis (PubMed:22212137, PubMed:23359680). Abrogates the ubiquitination of multiple proteins including WWTR1/TAZ, EGFR, HIF1A and beta-site amyloid precursor protein cleaving enzyme 1/BACE1 (PubMed:22212137, PubMed:25615526). In addition, recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin to maintain a stable pool of monoubiquitin that is a key requirement for the ubiquitin-proteasome and the autophagy-lysosome pathways (PubMed:12408865, PubMed:8639624, PubMed:9774100). Regulates amyloid precursor protein/APP processing by promoting BACE1 degradation resulting in decreased amyloid beta production (PubMed:22212137). Plays a role in the immune response by regulating the ability of MHC I molecules to reach cross-presentation compartments competent for generating Ag-MHC I complexes (By similarity). Mediates the 'Lys-48'-linked deubiquitination of the transcriptional coactivator WWTR1/TAZ leading to its stabilization and inhibition of osteoclastogenesis (By similarity). Deubiquitinates and stabilizes epidermal growth factor receptor EGFR to prevent its degradation and to activate its downstream mediators (By similarity). Modulates oxidative activity in skeletal muscle by regulating key mitochondrial oxidative proteins (By similarity). Enhances the activity of hypoxia-inducible factor 1-alpha/HIF1A by abrogateing its VHL E3 ligase-mediated ubiquitination and consequently inhibiting its degradation (PubMed:25615526).
Ubiquitin carboxyl-terminal hydrolase isozyme L1, UCH-L1, Neuron cytoplasmic protein 9.5, PGP 9.5, Ubiquitin thioesterase L1, PGP9.5, UCHL1
Rabbit Recombinant Monoclonal PGP9.5 antibody. Suitable for Flow Cyt, ICC, IHC-P, WB and reacts with Mouse, Human samples. Immunogen corresponding to Synthetic Peptide within Human UCHL1 aa 50-100.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline
Protein Gene Product 9.5 (PGP9.5) also known as ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) is an enzyme of approximately 27 kDa mass. PGP9.5 is highly expressed in neurons and neuroendocrine cells and is involved in the processing of ubiquitinated proteins. Ubiquitination and deubiquitination are critical for maintaining cellular protein homeostasis. PGP9.5 is present in the central and peripheral nervous systems. Researchers often utilize PGP9.5 as a neuronal marker due to its strong expression in nerve tissues. Antibody clone 13C4 is commonly used in PGP9.5 immunohistochemistry to visualize this protein in histopathology sections.
PGP9.5 plays a significant role in the ubiquitin-proteasome pathway where it regulates protein degradation. It functions by cleaving ubiquitin from ubiquitin-protein conjugates which can recycle ubiquitin for reuse impacting protein turnover. This process is important for removing misfolded or damaged proteins maintaining cellular integrity. PGP9.5 has not been documented as a part of any large multimeric complex; its action is rather individual yet vital in cellular processes.
PGP9.5 is an important participant in the ubiquitin-dependent proteolysis pathway. This pathway controls the degradation of proteins that regulate cell cycle differentiation and neuromodulation. PGP9.5 works in tandem with other proteins such as the proteasome complex to remove proteins tagged for destruction. Another important pathway linked with PGP9.5 is the neuronal development pathway in which its activity supports neuron growth and repair.
Defective PGP9.5 function associates mainly with neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. Mutations or dysregulation in PGP9.5 expression are implicated in the pathogenesis of these conditions affecting protein degradation and neuronal health. Other proteins like α-synuclein in Parkinson's disease interact with PGP9.5 pathways indicating their involvement in disease mechanisms. Researchers consider PGP9.5 a potential biomarker for neuronal pathology through methods like PGP9.5 IHC allowing for evaluation of nerve damage and neuroendocrine tumor diagnosis.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Samples: Whole cell lysate (50 µg) from TCMK-1, NIH 3T3, ND7/23 (10 µg), RenCa, and EL4 (10 µg) cells prepared using NETN lysis buffer. Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216 lot 1) used at 1:1000. Secondary:HRP-conjugated goat anti-rabbit IgG (A120-101P). Chemiluminescence with an exposure time of 30 seconds. Lower Panel: Rabbit anti-Actin recombinant monoclonal antibody [BLR057F] (A700-057).
All lanes: Western blot - Anti-UCHL1 antibody [BLR216K] - BSA free (ab314058) at 1/1000 dilution
Lane 1: TCMK-1 whole cell lysate at 50 µg
Lane 2: NIH 3T3 Whole cell lysate at 50 µg
Lane 3: ND7/23 Whole cell lysate at 10 µg
Lane 4: RenCa Whole cell lysate at 50 µg
Lane 5: EL4 Whole cell lysate at 50 µg
All lanes: HRP-conjugated goat anti-rabbit IgG
Samples: Whole cell lysate (10 µg) from SK-N-BE(2), Jurkat, HEK293T, LNCaP, and HeLa cells prepared using NETN lysis buffer. Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] used at 1:1000. Secondary: HRP-conjugated goat anti-rabbit IgG. Chemiluminescence with an exposure time of 30 seconds. Lower Panel: Rabbit anti-Actin recombinant monoclonal antibody [BLR057F]
All lanes: Western blot - Anti-UCHL1 antibody [BLR216K] - BSA free (ab314058) at 1/1000 dilution
Lane 1: SK-N-BE(2) whole cell lysate at 10 µg
Lane 2: Jurkat whole cell lysate at 10 µg
Lane 3: HEK293T whole cell lysate at 10 µg
Lane 4: LNCaP whole cell lysate at 10 µg
Lane 5: HeLa whole cell lysate at 10 µg
All lanes: HRP-conjugated goat anti-rabbit IgG
Detection of human UCHL1 by immunocytochemistry. Sample:FFPE section of DU145 cells (left -positive) and LNCaP cells (right -negative). Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216-1). Secondary:HRP-conjugated goat antirabbit IgG (A120-501P).
Detection of human UCHL1 by immunocytochemistry. Sample:FFPE section of ND7/23 cells. Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216-1). Secondary:HRP-conjugated goat antirabbit IgG (A120-501P).
Sample:FFPE section of mouse brain. Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216-1). Secondary:HRP-conjugated goat antirabbit IgG (A120-501P).
Detection of human UCHL1 by immunohistochemistry. Sample:FFPE section of prostate carcinoma. Antibody: Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216-1). Secondary:HRP-conjugated goat anti-rabbit IgG (A120-501P).
Detection of mouse UHCL1 (shaded) in EL4 cells by flow cytometry. Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216) or isotype control (unshaded). Secondary: DyLight® 650-conjugated goat anti-rabbit IgG (A120-101D5).
Detection of human UCHL1 (shaded) in A549 cells by flow cytometry. Antibody:Rabbit anti-UCHL1 recombinant monoclonal antibody [BLR216K] (A700-216) or isotype control (unshaded). Secondary: DyLight® 650-conjugated goat anti-rabbit IgG (A120-101D5).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com